Literature DB >> 2555188

Influence of endogenous opioids on atrial natriuretic factor release during exercise in man.

F Louisy1, C Y Guezennec, M Lartigue, J C Aldigier, F X Galen.   

Abstract

To evaluate to what extent opioid secretion in exercise induces the release of atrial natriuretic factor (ANF), six healthy male volunteers who were trained subjects, were submitted to two maximal exercise tests with and without (control) opioid receptor blockade by Naltrexone. Blood samples were drawn before (rest) and after exercise (post-exercise) in order to measure human ANF (alpha h ANF), beta-endorphin, plasma aldosterone concentration (PAC) plasma renin activity (PRA) and adreno-cortico trophic hormone (ATCH) by radio-immunological methods. Expired gas was collected during exercise to measure oxygen consumption. On average, the same maximal oxygen consumption (VO2max) during exercise was reached by all subjects with and without treatment. Plasma ANF level at rest slightly decreased after administration of Naltrexone; the response to physical exercise was significantly reduced by Naltrexone. There was no statistical difference between plasma levels of beta-endorphin, PRA and ACTH at rest nor in the post-exercise situation under the influence of Naltrexone. The PAC increased significantly at rest after Naltrexone administration but there was no statistical difference between both values after exercise. These data demonstrate that: (1) ANF secretion during exercise is influenced by the level of beta-endorphin in the plasma; (2) the possible inhibitory role of ANF on aldosterone secretion during exercise is probably over-ruled by the increase in plasma ACTH and PRA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555188     DOI: 10.1007/BF02396577

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  23 in total

1.  Effect of alpha-1 adrenoceptor blockade on plasma levels of atrial natriuretic peptide during dynamic exercise in normal man.

Authors:  N Keller; T Møller; R Sykulski; T L Storm; G M Thamsborg
Journal:  Horm Metab Res       Date:  1987-07       Impact factor: 2.936

2.  The concentration of atrial natriuretic peptide (ANP) is decreased in plasma but not in atria in hypophysectomised rats.

Authors:  O Arjamaa; H Ruskoaho; M Tuominen; O Vakkuri; J Leppäluoto
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

3.  Integrated cardiac and peripheral vascular response to atriopeptin 24 in conscious dogs.

Authors:  J T Shapiro; V M DeLeonardis; P Needleman; T H Hintze
Journal:  Am J Physiol       Date:  1986-12

Review 4.  Human cardiovascular adjustments to exercise and thermal stress.

Authors:  L B Rowell
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

5.  Dynorphin A-(1-10) amide stimulates the release of atrial natriuretic polypeptide (ANP) from rat atrium.

Authors:  J Tang; C W Xie; X Z Xie; X M Gao; J K Chang
Journal:  Eur J Pharmacol       Date:  1987-04-29       Impact factor: 4.432

6.  Epinephrine increases plasma immunoreactive atrial natriuretic hormone levels in humans.

Authors:  J A Sanfield; Y Shenker; R J Grekin; S G Rosen
Journal:  Am J Physiol       Date:  1987-06

7.  Differential effects of atrial natriuretic factor on angiotensin II- and adrenocorticotropin-stimulated aldosterone secretion.

Authors:  G Aguilera
Journal:  Endocrinology       Date:  1987-01       Impact factor: 4.736

8.  Effect of different anesthetics on immunoreactive atrial natriuretic factor concentrations in rat plasma.

Authors:  K Horký; J Gutkowska; R Garcia; G Thibault; J Genest; M Cantin
Journal:  Biochem Biophys Res Commun       Date:  1985-06-28       Impact factor: 3.575

9.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

10.  A dynorphin peptide induces hypotension by stimulating the release of atrial natriuretic peptide from rat atrium.

Authors:  C W Xie; L Y Yin; X Z Xie; X M Gao; Z Q Xia; J K Chang; J Tang
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

View more
  3 in total

1.  Renal effects of TAPP, a highly selective mu-opioid agonist.

Authors:  J Gutkowska; P W Schiller
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 2.  Changes in beta-endorphin levels in response to aerobic and anaerobic exercise.

Authors:  L Schwarz; W Kindermann
Journal:  Sports Med       Date:  1992-01       Impact factor: 11.136

3.  Advocating neuroimaging studies of transmitter release in human physical exercise challenges studies.

Authors:  Henning Boecker; Ahmed Othman; Sarah Mueckter; Lukas Scheef; Max Pensel; Marcel Daamen; Jakob Jankowski; Hh Schild; Tr Tölle; M Schreckenberger
Journal:  Open Access J Sports Med       Date:  2010-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.